DUBLIN--(BUSINESS WIRE)--The "CRO Quality Benchmarking - Phase I Service Providers (9th Edition)" report has been added to Research and Markets' offering.
CRO Quality Benchmarking - Phase I Service Providers (9th Edition) report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied performance ratings based on their own experiences with 46 Phase I CROs, making this report the most comprehensive assessment of CRO service quality in the industry. Now in its 9th year, this report has become a crucial tool for sponsors looking to select a Phase I CRO and for service providers seeking an experience-based evaluation of their strengths and weaknesses.
What You Will Learn:
Study Sponsors
- Make a more informed purchase of Phase I services by understanding which service providers best fit your company's needs
- Broaden your Phase I CRO evaluation list by accessing peer-based service quality ratings across 27 critical attributes
- Pinpoint potential delivery concerns early in a sponsor CRO relationship in order to develop proactive strategies to address potential gaps
Key Topics Covered:
1. Introduction
Methodology
Respondent Demographics
and Qualifications
Number of Ratings per Company
5 Major Sections
2. Service Provider Selection Process
Primary Section Takeaways
3. Service Provider Perceptions And Interactions
Primary Section Takeaways
Sponsor Size
4. Service Provider Performance And Loyalty
Primary Section Takeaways
Rolling Average
5. Company Service Quality Profiles
Biotrial
Celerion
Chiltern
Covance
Eurofins
ICON
INC Research
inVentiv Health Clinical
Lambda
Medpace
PAREXEL
PPD
PRA
QPS
Quintiles
Quotient Clinical
SGS Life Sciences
Worldwide Clinical Trials
6. Study Data
Phase I Leaders, Unprompted
Phase I Leaders, Prompted
Service Provider Familiarity
Service Provider Usage
Service Provider Preference
Service Provider Differentiation
Selection Drivers: Selecting among
Preferred Providers
Preferred Provider Attributes
Gaining Importance
Selection Drivers When Not Using
Preferred Providers
Selection Drivers: No Preferred Providers
Service Provider Attributes Gaining Importance:
No Preferred Providers
Service Provider Cost Perceptions
Use of Preferred Providers
Number of Preferred Providers
7. Service Provider Drill-Downs
Algorithme Pharma
BioPharma Services Inc.
BioSkin
BioTrial
Celerion
CHDR
Chiltern
Clinical Research Services (CRS)
Covance
DaVita Clinical Research
DCRI-Duke
Eurofins
Eurotrials
Frontage
HungaroTrial
ICON
Inamed
INC Research
inVentiv Health Clinical
KCR
Lambda
Medpace
Medsource
NAMSA
Novotech
Nuvisan
PAREXEL
Pharm-Olam International
PPD
PRA
ProTrials
QPS
Quintiles
Quotient Clinical
Rho
Sannova Analytical
SGS Life Sciences
Simbec
Siro Clinpharm
Spaulding Clinical
SynteractHCR
TKL Research
US Oncology
Vince & Associates
WCCT Global
Worldwide Clinical Trials
Performance Across Service Providers
8. Demographics
Company Size
Headquarters Location
Office Location
Job Title
Decision-making Responsibility
Outsourcing Involvement by Phase
Involvement in Clinical Development
Therapeutic Areas of Responsibility
Years of Industry Experience
Age
For more information about this report visit https://www.researchandmarkets.com/research/wdcnxf/cro_quality
